North America Cell & Gene Therapy Manufacturing Services Market: by Type (Allogeneic, Autologous, Viral Vector, Non-viral Vector, Plasmid DNA, Others), Application (Oncology, Cardiovascular Diseases, Neurological Disorders, Rare Diseases, Infectious Diseases, Others), Distribution Channels (Direct Tenders, Third-Party Distributors, Online Platforms, Others), Technology (Gene Editing, Cell Expansion, Viral Vector Production, Cryopreservation, Automation, Others), Organization Size (Small, Medium, Large) and By North America – Historical & Forecast Period (2020-2035) Comprehensive Study 2025

1. North America Cell & Gene Therapy Manufacturing Services Market Outlook

2. North America Cell & Gene Therapy Manufacturing Services Market Executive Summary

2.1. North America Market Revenue Size (USD Million) (2020-2035)

2.2. Key Trends By Segments (2020-2035)

2.3. Key Trends By North America (2020-2035)

3. North America Cell & Gene Therapy Manufacturing Services Market Key Vendors Analysis

3.1. Cell & Gene Therapy Manufacturing Services Market Regulatory Framework

3.2. Cell & Gene Therapy Manufacturing Services Market New Business and Ease of Doing Business Index

3.3. Cell & Gene Therapy Manufacturing Services Market Recent Developments

3.4. Top Cell & Gene Therapy Manufacturing Services Market Buyers Details By North America

3.5. Top Cell & Gene Therapy Manufacturing Services Market Suppliers Details By North America

3.6. Case Studies of Successful Key Ventures

3.7. Top Players Comparative Analysis

3.7.1. Country/Regions

3.8. Key Vendors

3.8.1. Top 5 Cell & Gene Therapy Manufacturing Services Market Vendors Pricing Analysis

3.8.2. Cell & Gene Therapy Manufacturing Services Market Product Benchmarking

3.8.3. Cell & Gene Therapy Manufacturing Services Market Future Investment Plans

3.9. Cell & Gene Therapy Manufacturing Services Market – Forces

3.9.1. Cell & Gene Therapy Manufacturing Services Market Drivers

3.9.2. Cell & Gene Therapy Manufacturing Services Market Restraints

3.9.3. Cell & Gene Therapy Manufacturing Services Market Challenges

3.9.3.1. Porter's Five Forces Analysis

3.9.3.1.1. Cell & Gene Therapy Manufacturing Services Market Bargaining Power of Suppliers

3.9.3.1.2. Cell & Gene Therapy Manufacturing Services Market Bargaining Power of Buyers

3.9.3.1.3. Cell & Gene Therapy Manufacturing Services Market Threat of New Entrants

3.9.3.1.4. Cell & Gene Therapy Manufacturing Services Market Threat of Substitutes

3.9.3.1.5. Cell & Gene Therapy Manufacturing Services Market Degree of Competition

4. North America Cell & Gene Therapy Manufacturing Services Market Revenue (USD Million) Size (2020-2035)- By Country Analysis

4.1. North America Cell & Gene Therapy Manufacturing Services Market Revenue (USD Million) By Country (2020-2035)

4.1.1. US

4.1.2. Canada

4.1.3. Mexico

5. North America Cell & Gene Therapy Manufacturing Services Market Revenue (USD Million) Size (2020-2035)- By Type

5.1. Allogeneic

5.2. Autologous

5.3. Viral Vector

5.4. Non-viral Vector

5.5. Plasmid DNA

5.6. Others

6. North America Cell & Gene Therapy Manufacturing Services Market Revenue (USD Million) Size (2020-2035)- By Application

6.1. Oncology

6.2. Cardiovascular Diseases

6.3. Neurological Disorders

6.4. Rare Diseases

6.5. Infectious Diseases

6.6. Others

7. North America Cell & Gene Therapy Manufacturing Services Market Revenue (USD Million) Size (2020-2035)- By Technology

7.1. Gene Editing

7.2. Cell Expansion

7.3. Viral Vector Production

7.4. Cryopreservation

7.5. Automation

7.6. Others

8. North America Cell & Gene Therapy Manufacturing Services Market Revenue (USD Million) Size (2020-2035)- By Distribution Channels

8.1. Direct Tenders

8.2. Third-Party Distributors

8.3. Online Platforms

8.4. Others

8.5. Hospital Pharmacies

8.6. Retail Pharmacies

9. North America Cell & Gene Therapy Manufacturing Services Market Revenue (USD Million) Size (2020-2035)- By Organization Size

9.1. Small

9.2. Medium

9.3. Large

10. Company Profile Analysis

10.1. Thermo Fisher Scientific

10.1.1. Vendors Overview

10.1.2. Business Portfolio

10.1.3. Geographical Portfolio

10.1.4. Customers

10.1.5. Financial Analysis

10.2. Lonza

10.3. Catalent

10.4. WuXi AppTec

10.5. Charles River Laboratories

10.6. Oxford Biomedica

10.7. Samsung Biologics

10.8. FUJIFILM Diosynth Biotechnologies

10.9. Bluebird Bio

10.10. Cell and Gene Therapy Catapult

10.11. uniQure

10.12. Novartis

10.13. BioNTech

10.14. Bristol Myers Squibb

10.15. Editas Medicine

11. Sources Covered

11.1. Primary Sources

11.2. Secondary Sources